openPR Logo
Press release

Roadside Drug Testing Devices Market Assessment and Forecast 2031

10-17-2022 08:31 AM CET | Health & Medicine

Press release from: Transparency Market Research

Roadside Drug Testing Devices Market

Roadside Drug Testing Devices Market

U.S. Roadside Drug Testing Devices Market Outlook 2031

The roadside drug testing devices market in the U.S. was valued at US$ 298.9 Mn in 2021

The market in the country is projected to expand at a CAGR of 5.3% from 2022 to 2031

The roadside drug testing devices market in the U.S. is anticipated to reach US$ 498.8 Mn by the end of 2031

Request A Free Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84814

Overview of U.S. Roadside Drug Testing Devices Market

Roadside drug testing devices are used to identify drugs consumed by an individual while driving. Devices used for drug testing include breathalyzers and drug test kits. It has become mandatory to conduct drug driving testing to prevent accidents and mishaps. In 2020, around 11,654 people died due to alcohol-impaired driving in the U.S., a 14% increase over that in 2019. Increase in the number of drug and alcohol abusers in the U.S. presents significant opportunities for test providers and manufacturers of drug abuse test products in the market.

Impact of Drug Abuse on Public Health to Drive Demand for Testing

Substance abuse has a significant effect on the health of individuals and their families. Abuse of prescription drugs or nonmedical use of prescription drugs has become a grave public health concern owing to its high prevalence and mortality rate in the U.S. Several individuals consume such drugs and drive, which leads to major accidents. Hence, roadside drug screening devices are used regularly to test individuals. This, in turn, propels the market in the country.

Read Report Overview: https://www.transparencymarketresearch.com/us-roadside-drug-testing-devices-market.html

Rise in prescription drug abuse increases the rate of overdose deaths and emergency room visits. Consumption of non-medical prescription drugs is rising at a rapid pace. According to the National Institute of Drug Abuse (NIDA), around 52 million people have used prescription drugs for non-medical reasons at least once in their lifetime. Vicodin and OxyContin are the most abused prescription drugs among the young population.

Technological Advancements in Testing Devices to Boost U.S. Roadside Drug Testing Devices Market

Technological advancements related to sample collection and efforts of manufacturers to create easy-to-use disposable test kits are expected to boost the demand for roadside drug testing devices. Manufacturers are focusing on using samples other than urine, such as sweat and hair, which are less embarrassing for individuals tested for drug abuse. They are also focusing on the development of rapid tests that provide faster results; and are easy to use and more affordable than wet tests. For instance, the DDS2 Mobile Test System, designed and manufactured by Alere, Inc. (Abbott), is a next-generation portable drug testing device. It detects if a driver is addicted to marijuana, opiates, amphetamines, and methamphetamines in a single oral fluid test within five minutes.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84814

Increase in Demand for Alcohol Testing Devices to Augment U.S. Roadside Drug Testing Devices Market

Based on substance, the roadside drug testing devices market in the U.S. has been bifurcated into drugs and alcohol. The drugs segment has been split into tetrahydrocannabinol (THC), amphetamine, and others. The alcohol segment dominated the market in the U.S. in 2021, accounting for around 62% share. The segment is likely to grow at a rapid pace during the forecast period. According to CDC, around 10,511 alcohol-impaired driving deaths occurred in the U.S. in 2018. Implementation of strategies to prevent alcohol and drug-impaired driving in the country is propelling the alcohol segment.

Higher Accuracy and Ease of Collection & Storage to Boost Urine Sample Segment

Based on sample, the roadside drug testing devices market in the U.S. has been segregated into saliva, breath, urine, and others. The urine segment held major share of around 42% in 2021. The trend is projected to continue during the forecast period. Urine samples are easy to store. Urine tests also give accurate results. These are non-invasive procedures used by professionals to detect illegal consumption of drugs. The breath segment held the second largest share of the market in the country in 2021. The segment is driven by the increase in the number of cases of driving under the influence of alcohol.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=84814

 High Portability and Low Cost to Drive Sales of Handheld Modality Devices

In terms of modality, the roadside drug testing devices market in the U.S. has been segregated into handheld and standalone. The handheld segment dominated the roadside drug testing devices market in the country in 2021, accounting for 73% share. The segment is anticipated to grow at the fastest CAGR during the forecast period. This can be attributed to high portability and low cost associated with handheld devices. Increase in sales of these compact roadside drug testing devices can be ascribed to their small size, speed, and reliability.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=84814

Analysis of Key Market Players in U.S. Roadside Drug Testing Devices Market

The roadside drug testing devices market report concludes with the company profiles section, which includes key information about leading players in the roadside drug testing devices market in the U.S. Most of the key players play an active role in the introduction of new mobile devices as well as point-of-care testing devices. Leading players in the roadside drug testing devices market in the country include Abbott, Quest Products, LLC, CareHealth America Corporation, Oranoxis, Inc., Drägerwerk AG & Co. KGaA, BACtrack, and Lifeloc Technologies, Inc.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Roadside Drug Testing Devices Market Assessment and Forecast 2031 here

News-ID: 2769048 • Views:

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights and
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughs
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examine

All 5 Releases


More Releases for Devices

Spinal Fusion Devices Market Size to Reach Valuation of $7.43 Billion by 2022 | …
Increase in adoption of minimally invasive spine surgery (MISS) presents lucrative opportunities for key players in the spinal fusion devices market. MISS is preferred to conventional techniques, owing to its associated benefits such as minimal cut or incision, which in turn reduces the chances of damage caused to the adjacent muscles. Spinal fusion devices market was valued at $5,867 million in 2015, and is projected to reach $7,435 million by 2022,
Global Beauty Devices Market Industry Insights Forecast to 2024, Coverage Cellul …
The global beauty devices market was valued at USD 39.1 billion in 2018 and is anticipated to grow at a CAGR of 18.4% during the forecast period. The significant growth in the beauty devices industry is imputed to the rise in prevalence of skin disorders, increasing rate of hormonal imbalance cases, an increase in the geriatric population, and growing awareness for beauty devices. Request for Free Sample Copy of this Research
Canada Anesthesia and Respiratory Devices Market Segments Including Airway Manag …
ReportsnReports added a new report on The Canada Anesthesia and Respiratory Devices Market report that delivers the clean elaborated structure of the Report comprising each and every business-related information of the market at a global level. The in-depth study on the current state which focuses on the major drivers and restraints for the key players. Canada Anesthesia and Respiratory Devices Market Industry research report provides granular analysis of the market
Global Beauty Devices Market Insights 2018 By Products Hair Growth Devices,Acne …
Description This report studies the global market size of Beauty Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Beauty Devices in these regions. This research report categorizes the global Beauty Devices market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers,
Wearable Electronic Devices Market,Wearable Electronic Devices Industry, Global …
Latest industry research report on: Global Wearable Electronic Devices Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Wearable Electronic Devices market status and forecast, categorizes the global Wearable Electronic Devices market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in United States, Europe, China, Japan, South Korea and Taiwan and other
Ophthalmic Devices Market By Product Function [Ophthalmic Surgery Devices (Refra …
Ophthalmology is a branch of medical sciences that deals with the structure, function, and various eye diseases. The ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices gain increased importance and adoption due to high prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision related issues. Request Sample At: https://www.bigmarketresearch.com/request-sample/1074435 Increase in prevalence rate of eye related diseases such as glaucoma, cataract,